aa
  • Search
  • Advanced Search

What's new?

April 1, 2025


Recent Updates on the Renoprotective Effects of Glucagon-Like Peptide 1 Receptor Agonists
Hong Sang Choi, Eun Hui Bae
Korean J Med. 2025;100(2):61-67.

Glucagon-like peptide 1 receptor agonists (GLP-1RA) significantly reduce the risk of cardiovascular disease. However, whether GLP-1RA improves clinically important renal outcomes is still unclear. In cardiovascular outcome trials of GLP-1RA,...

What's new?

April 1, 2025


Understanding Cardiovascular-Kidney-Metabolic Syndrome and the Necessity of a Multidisciplinary Approach
Inha Jung
Korean J Med. 2025;100(2):68-74.
Cardiovascular-kidney-metabolic (CKM) syndrome is a progressive disorder resulting from the complex interaction between metabolic risk factors, chronic kidney disease, and cardiovascular disease (CVD), leading to multi-organ dysfunction. Given the increasing...

In-depth review

April 1, 2025


Treatment Approaches for Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
Jeong Suk Koh, Ik-Chan Song
Korean J Med. 2025;100(2):75-80.
Philadelphia chromosome-like acute lymphoblastic leukemia (ALL) is a group of diseases that possess similar gene expression patterns to those of Philadelphia chromosome-positive ALL, but lack the BCR-ABL1 gene rearrangement and...
Current Issue
Volume 100(2); Apr 2025
Volume100 No. 2

Korean Journal
of Medicine

Print ISSN: 1738-9364
Online ISSN: 2289-0769

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2025 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next
Close layer
prev next